Az utóbbi években megerősítést nyert a fizikai teljesítmény jelentős mértékű genetikai meghatározottsága. Emellett a sportoláshoz köthető sérülésekre és betegségekre való genetikai hajlamról is egyre nagyobb ismeretanyag áll rendelkezésünkre. A teljesítményt befolyásoló génpolimorfizmusok vizsgálata lehetőséget kínál a sportági kiválasztási rendszer fejlesztésére. A sportoló genetikai profiljának ismerete a jövőben lehetővé teszi a személyre szabott edzésprogram kidolgozását és ezáltal a teljesítmény potenciális növelését. A genetikai tesztek a jövőben fontos szerepet játszhatnak a sérülések és a betegségek genetikai kockázati tényezőinek szűrésében is. Orv. Hetil., 2012, 153, 1247–1255.
Wackerhage, H., Miah, A., Harris, R. C., et al.: Genetic research and testing in sport and exercise science: a review of the issues. J. Sports Sci., 2009, 27, 1109–1116.
Harris R. C. , 'Genetic research and testing in sport and exercise science: a review of the issues ' (2009 ) 27 J. Sports Sci. : 1109 -1116 .
Bouchard, C., Leon, A. S., Rao, D. C., et al.: The HERITAGE family study. Aims, design, and measurement protocol. Med. Sci. Sports Exerc., 1995, 27, 721–729.
Rao D. C. , 'The HERITAGE family study. Aims, design, and measurement protocol ' (1995 ) 27 Med. Sci. Sports Exerc. : 721 -729 .
Perusse, L., Leblanc, C., Bouchard, C.: Familial resemblance in lifestyle components: results from the Canada Fitness Survey. Can. J. Public Health, 1988, 79, 201–205.
Bouchard C. , 'Familial resemblance in lifestyle components: results from the Canada Fitness Survey ' (1988 ) 79 Can. J. Public Health : 201 -205 .
Bouchard, C.: Genomic predictors of trainability. Exp. Physiol., 2012, 97, 347–352.
Bouchard C. , 'Genomic predictors of trainability ' (2012 ) 97 Exp. Physiol. : 347 -352 .
Sharp, N. C.: The human genome and sport, including epigenetics and athleticogenomics: a brief look at a rapidly changing field. J. Sports Sci., 2008, 26, 1127–1133.
Sharp N. C. , 'The human genome and sport, including epigenetics and athleticogenomics: a brief look at a rapidly changing field ' (2008 ) 26 J. Sports Sci. : 1127 -1133 .
Ostrander, E. A., Huson, H. J., Ostrander, G. K.: Genetics of athletic performance. Annu. Rev. Genomics Hum. Genet., 2009, 10, 407–429.
Ostrander G. K. , 'Genetics of athletic performance ' (2009 ) 10 Annu. Rev. Genomics Hum. Genet. : 407 -429 .
Rieder, M. J., Taylor, S. L., Clark, A. G., et al.: Sequence variation in the human angiotensin converting enzyme. Nat. Genet., 1999, 22, 59–62.
Clark A. G. , 'Sequence variation in the human angiotensin converting enzyme ' (1999 ) 22 Nat. Genet. : 59 -62 .
Rigat, B., Hubert, C., Alhenc-Gelas, F., et al.: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest., 1990, 86, 1343–1346.
Alhenc-Gelas F. , 'An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels ' (1990 ) 86 J. Clin. Invest. : 1343 -1346 .
Montgomery, H. E., Marshall, R., Hemingway, H., et al.: Human gene for physical performance. Nature, 1998, 393, 221–222.
Hemingway H. , 'Human gene for physical performance ' (1998 ) 393 Nature : 221 -222 .
Gayagay, G., Yu, B., Hambly, B., et al.: Elite endurance athletes and the ACE I allele – the role of genes in athletic performance. Hum. Genet., 1998, 103, 48–50.
Hambly B. , 'Elite endurance athletes and the ACE I allele – the role of genes in athletic performance ' (1998 ) 103 Hum. Genet. : 48 -50 .
Myerson, S., Hemingway, H., Budget, R., et al.: Human angiotensin I-converting enzyme gene and endurance performance. J. Appl. Physiol., 1999, 87, 1313–1316.
Budget R. , 'Human angiotensin I-converting enzyme gene and endurance performance ' (1999 ) 87 J. Appl. Physiol. : 1313 -1316 .
Tsianos, G., Sanders, J., Dhamrait, S., et al.: The ACE gene insertion/deletion polymorphism and elite endurance swimming. Eur. J. Appl. Physiol., 2004, 92, 360–362.
Dhamrait S. , 'The ACE gene insertion/deletion polymorphism and elite endurance swimming ' (2004 ) 92 Eur. J. Appl. Physiol. : 360 -362 .
Nazarov, I. B., Woods, D. R., Montgomery, H. E., et al.: The angiotensin converting enzyme I/D polymorphism in Russian athletes. Eur. J. Hum. Genet., 2001, 9, 797–801.
Montgomery H. E. , 'The angiotensin converting enzyme I/D polymorphism in Russian athletes ' (2001 ) 9 Eur. J. Hum. Genet. : 797 -801 .
Jones, A., Woods, D. R.: Skeletal muscle RAS and exercise performance. Int. J. Biochem. Cell Biol., 2003, 35, 855–866.
Woods D. R. , 'Skeletal muscle RAS and exercise performance ' (2003 ) 35 Int. J. Biochem. Cell Biol. : 855 -866 .
Zhang, B., Tanaka, H., Shono, N., et al.: The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle. Clin. Genet., 2003, 63, 139–144.
Shono N. , 'The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle ' (2003 ) 63 Clin. Genet. : 139 -144 .
Gordon, S. E., Davis, B. S., Carlson, C. J., et al.: ANG II is required for optimal overload-induced skeletal muscle hypertrophy. Am. J. Physiol. Endocrinol. Metab., 2001, 280, E150–E159.
Carlson C. J. , 'ANG II is required for optimal overload-induced skeletal muscle hypertrophy ' (2001 ) 280 Am. J. Physiol. Endocrinol. Metab. : E150 -E159 .
Folland, J., Leach, B., Little, T., et al.: Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp. Physiol., 2000, 85, 575–579.
Little T. , 'Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload ' (2000 ) 85 Exp. Physiol. : 575 -579 .
Rattigan, S., Dora, K. A., Tong, A. C., et al.: Perfused skeletal muscle contraction and metabolism improved by angiotensin II-mediated vasoconstriction. Am. J. Physiol., 1996, 271, E96–E103.
Tong A. C. , 'Perfused skeletal muscle contraction and metabolism improved by angiotensin II-mediated vasoconstriction ' (1996 ) 271 Am. J. Physiol. : E96 -E103 .
Beggs, A. H., Byers, T. J., Knoll, J. H., et al.: Cloning and characterization of two human skeletal muscle alpha-actinin genes located on chromosomes 1 and 11. J. Biol. Chem., 1992, 267, 9281–8288.
Knoll J. H. , 'Cloning and characterization of two human skeletal muscle alpha-actinin genes located on chromosomes 1 and 11 ' (1992 ) 267 J. Biol. Chem. : 9281 -8288 .
North, K. N., Yang, N., Wattanasirichaigoon, D., et al.: A common nonsense mutation results in alpha-actinin-3 deficiency in the general population. Nat. Genet., 1999, 21, 353–354.
Wattanasirichaigoon D. , 'A common nonsense mutation results in alpha-actinin-3 deficiency in the general population ' (1999 ) 21 Nat. Genet. : 353 -354 .
Mills, M., Yang, N., Weinberger, R., et al.: Differential expression of the actin-binding proteins, alpha-actinin-2 and -3, in different species: implications for the evolution of functional redundancy. Hum. Mol. Genet., 2001, 10, 1335–1346.
Weinberger R. , 'Differential expression of the actin-binding proteins, alpha-actinin-2 and -3, in different species: implications for the evolution of functional redundancy ' (2001 ) 10 Hum. Mol. Genet. : 1335 -1346 .
MacArthur, D. G., Seto, J. T., Chan, S., et al.: An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance. Hum. Mol. Genet., 2008, 17, 1076–1086.
Chan S. , 'An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance ' (2008 ) 17 Hum. Mol. Genet. : 1076 -1086 .
Berman, Y., North, K. N.: A gene for speed: the emerging role of alpha-actinin-3 in muscle metabolism. Physiology (Bethesda), 2010, 25, 250–259.
North K. N. , 'A gene for speed: the emerging role of alpha-actinin-3 in muscle metabolism ' (2010 ) 25 Physiology (Bethesda) : 250 -259 .
Moran, C. N., Yang, N., Bailey, M. E., et al.: Association analysis of the ACTN3 R577X polymorphism and complex quantitative body composition and performance phenotypes in adolescent Greeks. Eur. J. Hum. Genet., 2007, 15, 88–93.
Bailey M. E. , 'Association analysis of the ACTN3 R577X polymorphism and complex quantitative body composition and performance phenotypes in adolescent Greeks ' (2007 ) 15 Eur. J. Hum. Genet. : 88 -93 .
Yang, N., MacArthur, D. G., Gulbin, J. P., et al.: ACTN3 genotype is associated with human elite athletic performance. Am. J. Hum. Genet., 2003, 73, 627–631.
Gulbin J. P. , 'ACTN3 genotype is associated with human elite athletic performance ' (2003 ) 73 Am. J. Hum. Genet. : 627 -631 .
Lucia, A., Gomez-Gallego, F., Santiago, C., et al.: ACTN3 genotype in professional endurance cyclists. Int. J. Sports Med., 2006, 27, 880–884.
Santiago C. , 'ACTN3 genotype in professional endurance cyclists ' (2006 ) 27 Int. J. Sports Med. : 880 -884 .
Lentes, K. U., Berrettini, W. H., Hoehe, M. R., et al.: A biallelic DNA polymorphism of the human beta-2-adrenergic receptor detected by Ban I-Adrbr-2. Nucleic Acids Res., 1988, 16, 2359.
Hoehe M. R. , 'A biallelic DNA polymorphism of the human beta-2-adrenergic receptor detected by Ban I-Adrbr-2 ' (1988 ) 16 Nucleic Acids Res. : 2359 -.
Wolfarth, B., Rankinen, T., Muhlbauer, S., et al.: Association between a beta2-adrenergic receptor polymorphism and elite endurance performance. Metabolism., 2007, 56, 1649–1651.
Muhlbauer S. , 'Association between a beta2-adrenergic receptor polymorphism and elite endurance performance ' (2007 ) 56 Metabolism. : 1649 -1651 .
Moore, G. E., Shuldiner, A. R., Zmuda, J. M., et al.: Obesity gene variant and elite endurance performance. Metabolism, 2001, 50, 1391–1392.
Zmuda J. M. , 'Obesity gene variant and elite endurance performance ' (2001 ) 50 Metabolism : 1391 -1392 .
Lucia, A., Gomez-Gallego, F., Barroso, I., et al.: PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men. J. Appl. Physiol., 2005, 99, 344–348.
Barroso I. , 'PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men ' (2005 ) 99 J. Appl. Physiol. : 344 -348 .
Maciejewska, A., Sawczuk, M., Cieszczyk, P., et al.: The PPARGC1A gene Gly482Ser in Polish and Russian athletes. J. Sports Sci., 2012, 30, 101–113.
Cieszczyk P. , 'The PPARGC1A gene Gly482Ser in Polish and Russian athletes ' (2012 ) 30 J. Sports Sci. : 101 -113 .
Stefan, N., Thamer, C., Staiger, H., et al.: Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention. J. Clin. Endocrinol. Metab., 2007, 92, 1827–1833.
Staiger H. , 'Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention ' (2007 ) 92 J. Clin. Endocrinol. Metab. : 1827 -1833 .
Akhmetov, I. I., Popov, D. V., Mozhaiskaia, I. A., et al.: Association of regulatory genes polymorphisms with aerobic and anaerobic performance of athletes. Ross. Fiziol. Zh. Im. I. M. Sechenova, 2007, 93, 837–843.
Mozhaiskaia I. A. , 'Association of regulatory genes polymorphisms with aerobic and anaerobic performance of athletes ' (2007 ) 93 Ross. Fiziol. Zh. Im. I. M. Sechenova : 837 -843 .
Westerblad, H., Dahlstedt, A. J., Lannergren, J.: Mechanisms underlying reduced maximum shortening velocity during fatigue of intact, single fibres of mouse muscle. J. Physiol., 1998, 510 (Pt 1), 269–277.
Lannergren J. , 'Mechanisms underlying reduced maximum shortening velocity during fatigue of intact, single fibres of mouse muscle ' (1998 ) 510 J. Physiol. : 269 -277 .
Morisaki, T., Gross, M., Morisaki, H., et al.: Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc. Natl. Acad. Sci. USA, 1992, 89, 6457–6461.
Morisaki H. , 'Molecular basis of AMP deaminase deficiency in skeletal muscle ' (1992 ) 89 Proc. Natl. Acad. Sci. USA : 6457 -6461 .
Kar, N. C., Pearson, C. M.: Muscle adenylate deaminase deficiency. Report of six new cases. Arch. Neurol., 1981, 38, 279–281.
Pearson C. M. , 'Muscle adenylate deaminase deficiency. Report of six new cases ' (1981 ) 38 Arch. Neurol. : 279 -281 .
Rubio, J. C., Martin, M. A., Rabadan, M., et al.: Frequency of the C34T mutation of the AMPD1 gene in world-class endurance athletes: does this mutation impair performance? J. Appl. Physiol., 2005, 98, 2108–2112.
Rabadan M. , 'Frequency of the C34T mutation of the AMPD1 gene in world-class endurance athletes: does this mutation impair performance? ' (2005 ) 98 J. Appl. Physiol. : 2108 -2112 .
Rico-Sanz, J., Rankinen, T., Joanisse, D. R., et al.: Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family Study. Physiol. Genomics, 2003, 14, 161–166.
Joanisse D. R. , 'Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family Study ' (2003 ) 14 Physiol. Genomics : 161 -166 .
McPherron, A. C., Lawler, A. M., Lee, S. J.: Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature, 1997, 387, 83–90.
Lee S. J. , 'Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member ' (1997 ) 387 Nature : 83 -90 .
Grobet, L., Martin, L. J., Poncelet, D., et al.: A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat. Genet., 1997, 17, 71–74.
Poncelet D. , 'A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle ' (1997 ) 17 Nat. Genet. : 71 -74 .
Mosher, D. S., Quignon, P., Bustamante, C. D., et al.: A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS Genet., 2007, 3, e79.
Bustamante C. D. , 'A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs ' (2007 ) 3 PLoS Genet. : e79 -.
Furalyov, V. A., Kravchenko, I. V., Khotchenkov, V. P., et al.: SiRNAs targeting mouse myostatin. Biochemistry (Mosc), 2008, 73, 342–345.
Khotchenkov V. P. , 'SiRNAs targeting mouse myostatin ' (2008 ) 73 Biochemistry (Mosc) : 342 -345 .
Magee, T. R., Artaza, J. N., Ferrini, M. G., et al.: Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass. J. Gene Med., 2006, 8, 1171–1181.
Ferrini M. G. , 'Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass ' (2006 ) 8 J. Gene Med. : 1171 -1181 .
Zipes, D. P., Camm, A. J., Borggrefe, M., et al.: ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation, 2006, 114, e385–e484.
Borggrefe M. , 'ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society ' (2006 ) 114 Circulation : e385 -e484 .
Pigozzi, F., Rizzo, M.: Sudden death in competitive athletes. Clin. Sports Med., 2008, 27, 153–181, ix.
Rizzo M. , 'Sudden death in competitive athletes ' (2008 ) 27 Clin. Sports Med. : 153 -181, ix .
Corrado, D., Migliore, F., Basso, C., et al.: Exercise and the risk of sudden cardiac death. Herz, 2006, 31, 553–558.
Basso C. , 'Exercise and the risk of sudden cardiac death ' (2006 ) 31 Herz : 553 -558 .
Chopra, N., Knollmann, B. C.: Genetics of sudden cardiac death syndromes. Curr. Opin. Cardiol., 2011, 26, 196–203.
Knollmann B. C. , 'Genetics of sudden cardiac death syndromes ' (2011 ) 26 Curr. Opin. Cardiol. : 196 -203 .
Jozsa, L., Balint, J. B., Kannus, P., et al.: Distribution of blood groups in patients with tendon rupture. An analysis of 832 cases. J. Bone Joint Surg. Br., 1989, 71, 272–274.
Kannus P. , 'Distribution of blood groups in patients with tendon rupture. An analysis of 832 cases ' (1989 ) 71 J. Bone Joint Surg. Br. : 272 -274 .
Mokone, G. G., Gajjar, M., September, A. V., et al.: The guanine-thymine dinucleotide repeat polymorphism within the tenascin-C gene is associated with achilles tendon injuries. Am. J. Sports Med., 2005, 33, 1016–1021.
September A. V. , 'The guanine-thymine dinucleotide repeat polymorphism within the tenascin-C gene is associated with achilles tendon injuries ' (2005 ) 33 Am. J. Sports Med. : 1016 -1021 .
Mokone, G. G., Schwellnus, M. P., Noakes, T. D., et al.: The COL5A1 gene and Achilles tendon pathology. Scand J. Med. Sci. Sports, 2006, 16, 19–26.
Noakes T. D. , 'The COL5A1 gene and Achilles tendon pathology ' (2006 ) 16 Scand J. Med. Sci. Sports : 19 -26 .
Raleigh, S. M., van der Merwe, L., Ribbans, W. J., et al.: Variants within the MMP3 gene are associated with Achilles tendinopathy: possible interaction with the COL5A1 gene. Br. J. Sports Med., 2009, 43, 514–520.
Ribbans W. J. , 'Variants within the MMP3 gene are associated with Achilles tendinopathy: possible interaction with the COL5A1 gene ' (2009 ) 43 Br. J. Sports Med. : 514 -520 .
Khoschnau, S., Melhus, H., Jacobson, A., et al.: Type I collagen alpha1 Sp1 polymorphism and the risk of cruciate ligament ruptures or shoulder dislocations. Am. J. Sports Med., 2008, 36, 2432–2436.
Jacobson A. , 'Type I collagen alpha1 Sp1 polymorphism and the risk of cruciate ligament ruptures or shoulder dislocations ' (2008 ) 36 Am. J. Sports Med. : 2432 -2436 .
Savulescu, J., Foddy, B.: Comment: genetic test available for sports performance. Br. J. Sports Med., 2005, 39, 472.
Foddy B. , 'Comment: genetic test available for sports performance ' (2005 ) 39 Br. J. Sports Med. : 472 -.
Sótonyi, G., Papp, J.: Reflections on the enforcement of the genetic code of Act No. XXI of 2008. [Reflexiók a 2008. évi XXI. genetikai törvény végrehajtásához.] Orv. Hetil., 2012, 153, 683–689. [Hungarian]
Papp J. , 'Reflections on the enforcement of the genetic code of Act No. XXI of 2008. [Reflexiók a 2008. évi XXI. genetikai törvény végrehajtásához.] ' (2012 ) 153 Orv. Hetil. : 683 -689 .
Jordan, B. D., Relkin, N. R., Ravdin, L. D., et al.: Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. JAMA, 1997, 278, 136–140.
Ravdin L. D. , 'Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing ' (1997 ) 278 JAMA : 136 -140 .
Hudson, K. L., Holohan, M. K., Collins, F. S.: Keeping pace with the times – the Genetic Information Nondiscrimination Act of 2008. N. Engl. J. Med., 2008, 358, 2661–2663.
Collins F. S. , 'Keeping pace with the times – the Genetic Information Nondiscrimination Act of 2008 ' (2008 ) 358 N. Engl. J. Med. : 2661 -2663 .
Rivera, M. A., Dionne, F. T., Simoneau, J. A., et al.: Muscle-specific creatine kinase gene polymorphism and VO2max in the HERITAGE Family Study. Med. Sci. Sports Exerc., 1997, 29, 1311–1317.
Simoneau J. A. , 'Muscle-specific creatine kinase gene polymorphism and VO2max in the HERITAGE Family Study ' (1997 ) 29 Med. Sci. Sports Exerc. : 1311 -1317 .
Doring, F., Onur, S., Fischer, A., et al.: A common haplotype and the Pro582Ser polymorphism of the hypoxia-inducible factor-1alpha (HIF1A) gene in elite endurance athletes. J. Appl. Physiol., 2010, 108, 1497–1500.
Fischer A. , 'A common haplotype and the Pro582Ser polymorphism of the hypoxia-inducible factor-1alpha (HIF1A) gene in elite endurance athletes ' (2010 ) 108 J. Appl. Physiol. : 1497 -1500 .
Ahmetov, I. I., Hakimullina, A. M., Lyubaeva, E. V., et al.: Effect of HIF1A gene polymorphism on human muscle performance. Bull. Exp. Biol. Med., 2008, 146, 351–353.
Lyubaeva E. V. , 'Effect of HIF1A gene polymorphism on human muscle performance ' (2008 ) 146 Bull. Exp. Biol. Med. : 351 -353 .
Williams, A. G., Dhamrait, S. S., Wootton, P. T., et al.: Bradykinin receptor gene variant and human physical performance. J. Appl. Physiol., 2004, 96, 938–942.
Wootton P. T. , 'Bradykinin receptor gene variant and human physical performance ' (2004 ) 96 J. Appl. Physiol. : 938 -942 .
Gomez-Gallego, F., Ruiz, J. R., Buxens, A., et al.: The -786 T/C polymorphism of the NOS3 gene is associated with elite performance in power sports. Eur. J. Appl. Physiol., 2009, 107, 565–569.
Buxens A. , 'The -786 T/C polymorphism of the NOS3 gene is associated with elite performance in power sports ' (2009 ) 107 Eur. J. Appl. Physiol. : 565 -569 .
Santiago, C., Ruiz, J. R., Rodriguez-Romo, G., et al.: The K153R polymorphism in the myostatin gene and muscle power phenotypes in young, non-athletic men. PLoS One, 2011, 6, e16323.
Rodriguez-Romo G. , 'The K153R polymorphism in the myostatin gene and muscle power phenotypes in young, non-athletic men ' (2011 ) 6 PLoS One : e16323 -.